Kennedy Capital Management, Inc. Sutro Biopharma, Inc. Transaction History

Kennedy Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $3,603 - $6,226	1,102 Added 3.69%	30,947 $174,000
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $61,779 - $135,496	29,845 New	29,845 $128,000
Q2 2022 Aug 10, 2022	BUY	$3.41 - $8.95 $426 - $1,118	125 Added 0.11%	114,437 $596,000
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $105,909 - $208,415	-13,613 Reduced 10.64%	114,312 $940,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $55,104 - $90,990	-3,867 Reduced 2.93%	127,925 $1.9 Million
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $6,448 - $8,549	-382 Reduced 0.29%	131,792 $2.49 Million
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $164,361 - $217,143	-9,116 Reduced 6.45%	132,174 $2.46 Million
Q1 2021 May 14, 2021	SELL	$20.29 - $27.54 $182,467 - $247,667	-8,993 Reduced 5.98%	141,290 $3.22 Million
Q4 2020 Feb 12, 2021	BUY	$10.16 - $23.98 $1.53 Million - $3.6 Million	150,283 New	150,283 $3.26 Million

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $139M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.